Asia
Four patients with spinal cord injuries will receive nerve cells made from induce pluripotent stem cells in hopes of regaining sensation and mobility lost as a result of the injury.
Teva Pharmaceuticals is expecting big things from its generic EpiPen. The company snagged approval for its generic version of Mylan’s EpiPen Auto-Injector in August 2018.
Study was conducted on 36 kidney cancer patients using the CLEARScore™ test that identifies eight genes linked to immunotherapy
The hospital’s ASP has been designed to regulate the overuse of antibiotics
Could a drug used to treat tapeworms be effective at treating a type of cancer? Researchers in Singapore think they are on the right track in demonstrating just that.
Mumbai-based Glenmark Pharmaceuticals is spinning off its innovation business into a standalone company based in the United States. The new business will have its own chief executive officer and board of directors.
Singapore clinicians and scientists have discovered an unprecedented use of an FDA-approved drug to kill p53-defective cancer cells
Following international concern and outrage over a gene editing treatment of human embryos in China, the World Health Organization is taking action.
Denmark’s H. Lundbeck and Japan’s Otsuka Pharmaceutical announced that their brexpiprazole failed to meet its primary endpoint in two Phase III clinical trials to treat manic episodes in patients with bipolar I disorder.
Results Confirm and Extend 40-Week Findings that Treatment with Crysvita is Superior to Conventional Therapy
PRESS RELEASES